LATE-BREAKING ABSTRACT: One-year adherence to CPAP treatment in cardiac patients with non-sleepy sleep apnoea in the RICCADSA trial

Y. Peker, Y. Turgut Celen, A. Stålkrantz, H. Glantz, O. Sengören Dikis, B. Cederin, S. Korkmaz, E. Thunström (Skövde, Gothenburg, Sweden)

Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Session: Metabolic and cardiovascular consequences of OSA II
Session type: Thematic Poster Session
Number: 3866
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Peker, Y. Turgut Celen, A. Stålkrantz, H. Glantz, O. Sengören Dikis, B. Cederin, S. Korkmaz, E. Thunström (Skövde, Gothenburg, Sweden). LATE-BREAKING ABSTRACT: One-year adherence to CPAP treatment in cardiac patients with non-sleepy sleep apnoea in the RICCADSA trial. Eur Respir J 2012; 40: Suppl. 56, 3866

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Long-term outcome of nCPAP therapy in sleep apnoea patients
Source: Eur Respir J 2004; 24: Suppl. 48, 569s
Year: 2004

Adherence and satisfaction with CPAP therapy among sleep apnea patients: telematic compared with conventional follow-up
Source: Sleep and Breathing Conference 2021
Year: 2021




LATE-BREAKING ABSTRACT: The Sleep Apnea cardioVascular Endpoints (SAVE) study results – A trial of CPAP versus usual care in 2717 high cardiovascular risk patients with moderate-severe obstructive sleep apnea (OSA)
Source: International Congress 2016 – Cardiovascular and metabolic pathophysiology and outcomes of obstructive sleep apnoea
Year: 2016


CPAP treatment increases anxiety in coronary artery disease patients with nonsleepy obstructive sleep apnoea: The RICCADSA randomized controlled trial
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020


Cognition, quality of life and adherence to CPAP after 18-months treatment in obstructive sleep apnea patients
Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea
Year: 2011

LATE-BREAKING ABSTRACT: Morbidity and mortality of chronic heart failure (CHF) patients with central sleep apnoea (CSA) treated by adaptive servoventilation (ASV): Interim results of FACE cohort study
Source: International Congress 2016 – Technical aspects, compliance, and adherence to positive airway pressure in sleep apnoea
Year: 2016


Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002

A 6-month open-label study to assess the safety and effectiveness of nCPAP treatment in children <30kg with obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2008 - Sleep apnoea in childhood
Year: 2008

Long-term CPAP compliance in women with obstructive sleep apnoea
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012


Long-term effects of CPAP on blood pressure in non-resistant hypertensive patients with obstructive sleep apnea: A 30 month prospective study
Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels
Year: 2016

Impact of a multimodal telemonitoring intervention on CPAP adherence in symptomatic low-cardiovascular risk sleep apnea: a randomized controlled trial
Source: Virtual Congress 2020 – The impact of different treatment modalities on obstructive sleep apnoea
Year: 2020




Impact in adherence to CPAP treatment of a specific consultation for patients with severo obstructive sleep apnoea
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020


Web-based follow-up of CPAP compliance in obstructive sleep apnea syndrome: A pilot study
Source: Annual Congress 2011 - Epidemiology, diagnosis and treatment in obstructive sleep apnoea
Year: 2011


LATE-BREAKING ABSTRACT: Heart rate variability (HRV) in patients with severe obstructive sleep apnea syndrome (OSA) and its response to a 3-month continuous positive airway pressure (CPAP) therapy
Source: International Congress 2014 – Sleep disordered breathing 4
Year: 2014


LATE-BREAKING ABSTRACT: ORCADES: a prospective cohort study of severe obstructive sleep apnoea (OSA) patients receiving second line-treatment with a mandibular repositioning device (MRD)
Source: Annual Congress 2013 –New physiologic boundaries
Year: 2013


Utility of a nurse-led visit program for patients with obstructive sleep apnea syndrome treated with CPAP
Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health
Year: 2012

cPAP compliance and survival in elderly and sleep apnoea patients
Source: Annual Congress 2011 - Obstructive sleep apnoea in children and adults
Year: 2011


The effects of short-term CPAP withdrawal on myocardial perfusion in OSA – A randomised placebo-controlled trial
Source: International Congress 2014 – Real or not? The impact of OSA and CPAP on comorbid conditions
Year: 2014

Obstructive sleep apnea (OSA) in elderly patients. Role of continuos positive airway pressure (CPAP) treatment. A multicenter randomized controlled clinical trial
Source: International Congress 2014 – Three ages of man: OSA in children, adults and the elderly
Year: 2014



Determinants of CPAP compliance in bariatric patients with obstructive sleep apnoea
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017